Business
EU regulators reviewing J&J’s COVID vaccine after blood clots – Aljazeera.com
Johnson & Johnson is working with EU regulators to assess data on the rare clots, the company said in a statement.
The European Unions drug regulator has started a review to assess blood clots in people who received Johnson & Johnsons Covid-19 vaccine.
Four serious cases of unusual clots accompanied by low blood platelets, one of which was fatal, have emerged after immunization with the J&J shot, the European Medicines Agency said Friday. The regulator is now scrutinizing potential safety issues for two Covid vaccines, after AstraZeneca Plcs shot was possibly linked to a rare blood-clotting disorder.
J&J is…
-
Noosa News7 hours ago‘Just want to know he’s safe’: Family’s German Shepherd asleep in back of stolen ute
-
General17 hours agoAFL gives teams finishing 10th chance to win premiership through wildcard round in finals
-
Noosa News16 hours agoMan allegedly exposed himself to teen girls in Newstead, Springfield; Dingo snatches shark on K’gari; BBC boss and news chief quit over Trump video outrage
-
Noosa News13 hours agoDingo hunts shark in shallow waters off K’gari, Queensland